* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID	Gene_Symbol	DisGeNet_diseaseID	Disease_name	DisGeNet score	DisGeNet_sourceDB
2048	EPHB2	C0376358	Malignant neoplasm of prostate	0.211198285618107	BEFREE;GAD;UNIPROT
2048	EPHB2	C0014474	Ependymoma	0.200549453568426	BEFREE;CTD_human
2048	EPHB2	C2931456	Prostate cancer, familial	0.200274726784213	BEFREE;ORPHANET
2048	EPHB2	C1863600	PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY (finding)	0.2	CTD_human
2048	EPHB2	C0025202	melanoma	0.0148352463475074	BEFREE
2048	EPHB2	C0009404	Colorectal Neoplasms	0.0128547373487467	BEFREE;LHGDN
2048	EPHB2	C0027627	Neoplasm Metastasis	0.0123483499122723	BEFREE;LHGDN
2048	EPHB2	C1527249	Colorectal Cancer	0.0122971927549596	BEFREE;GAD
2048	EPHB2	C0678222	Breast Carcinoma	0.0107143445843109	BEFREE
2048	EPHB2	C0006142	Malignant neoplasm of breast	0.0104396178000978	BEFREE
2048	EPHB2	C0009402	Colorectal Carcinoma	0.0093407106632454	BEFREE
2048	EPHB2	C0596263	Carcinogenesis	0.0087912570948192	BEFREE
2048	EPHB2	C0017638	Glioma	0.00822744814907575	BEFREE;LHGDN
2048	EPHB2	C2239176	Liver carcinoma	0.0074176231737537	BEFREE
2048	EPHB2	C0600139	Prostate carcinoma	0.0071428963895406	BEFREE
2048	EPHB2	C0038356	Stomach Neoplasms	0.0057405517138406	BEFREE;LHGDN
2048	EPHB2	C0699791	Stomach Carcinoma	0.0052198089000489	BEFREE
2048	EPHB2	C0024623	Malignant neoplasm of stomach	0.0049450821158358	BEFREE
2048	EPHB2	C0029925	Ovarian Carcinoma	0.0043956285474096	BEFREE
2048	EPHB2	C0346647	Malignant neoplasm of pancreas	0.0035714481947703	BEFREE
2048	EPHB2	C0026764	Multiple Myeloma	0.0035714481947703	BEFREE
2048	EPHB2	C0235974	Pancreatic carcinoma	0.0035714481947703	BEFREE
2048	EPHB2	C0700095	Central neuroblastoma	0.0032967214105572	BEFREE
2048	EPHB2	C1140680	Malignant neoplasm of ovary	0.0032967214105572	BEFREE
2048	EPHB2	C0007131	Non-Small Cell Lung Carcinoma	0.0032967214105572	BEFREE
2048	EPHB2	C0017636	Glioblastoma	0.0032967214105572	BEFREE
2048	EPHB2	C0027819	Neuroblastoma	0.0032967214105572	BEFREE
2048	EPHB2	C0549473	Thyroid carcinoma	0.0030219946263441	BEFREE
2048	EPHB2	C0699790	Colon Carcinoma	0.0030219946263441	BEFREE
2048	EPHB2	C0007102	Malignant tumor of colon	0.0030219946263441	BEFREE
2048	EPHB2	C0033578	Prostatic Neoplasms	0.00300763924902685	BEFREE;LHGDN
2048	EPHB2	C0024141	Lupus Erythematosus, Systemic	0.002747267842131	BEFREE
2048	EPHB2	C0030567	Parkinson Disease	0.0026817553075011	BEFREE;GAD
2048	EPHB2	C0002395	Alzheimer's Disease	0.0024725410579179	BEFREE
2048	EPHB2	C0028326	Noonan Syndrome	0.0024725410579179	BEFREE
2048	EPHB2	C0041409	Turner Syndrome, Male	0.0024725410579179	BEFREE
2048	EPHB2	C0178874	Tumor Progression	0.0024725410579179	BEFREE
2048	EPHB2	C0332996	Persistent embryonic structure	0.0024725410579179	BEFREE
2048	EPHB2	C0007115	Malignant neoplasm of thyroid	0.0021978142737048	BEFREE
2048	EPHB2	C0585442	Osteosarcoma of bone	0.0019230874894917	BEFREE
2048	EPHB2	C0001418	Adenocarcinoma	0.0019230874894917	BEFREE
2048	EPHB2	C3539878	Triple Negative Breast Neoplasms	0.0019230874894917	BEFREE
2048	EPHB2	C0023903	Liver neoplasms	0.0019230874894917	BEFREE
2048	EPHB2	C0029463	Osteosarcoma	0.0019230874894917	BEFREE
2048	EPHB2	C0684249	Carcinoma of lung	0.0016483607052786	BEFREE
2048	EPHB2	C0003873	Rheumatoid Arthritis	0.0016483607052786	BEFREE
2048	EPHB2	C0004096	Asthma	0.0016483607052786	BEFREE
2048	EPHB2	C1306460	Primary malignant neoplasm of lung	0.0016483607052786	BEFREE
2048	EPHB2	C1335302	Pancreatic Ductal Adenocarcinoma	0.0016483607052786	BEFREE
2048	EPHB2	C0023434	Chronic Lymphocytic Leukemia	0.0016483607052786	BEFREE
2048	EPHB2	C0023467	Leukemia, Myelocytic, Acute	0.0016483607052786	BEFREE
2048	EPHB2	C0035412	Rhabdomyosarcoma	0.0016483607052786	BEFREE
2048	EPHB2	C0238463	Papillary thyroid carcinoma	0.0016483607052786	BEFREE
2048	EPHB2	C0242379	Malignant neoplasm of lung	0.0016483607052786	BEFREE
2048	EPHB2	C0409974	Lupus Erythematosus	0.0013736339210655	BEFREE
2048	EPHB2	C0476089	Endometrial Carcinoma	0.0013736339210655	BEFREE
2048	EPHB2	C0677886	Epithelial ovarian cancer	0.0013736339210655	BEFREE
2048	EPHB2	C2931822	Nasopharyngeal carcinoma	0.0013736339210655	BEFREE
2048	EPHB2	C0024131	Lupus Vulgaris	0.0013736339210655	BEFREE
2048	EPHB2	C0024138	Lupus Erythematosus, Discoid	0.0013736339210655	BEFREE
2048	EPHB2	C0024299	Lymphoma	0.0013736339210655	BEFREE
2048	EPHB2	C0345904	Malignant neoplasm of liver	0.0010989071368524	BEFREE
2048	EPHB2	C0424295	Hyperactive behavior	0.0010989071368524	BEFREE
2048	EPHB2	C0001430	Adenoma	0.0010989071368524	BEFREE
2048	EPHB2	C0004114	Astrocytoma	0.0010989071368524	BEFREE
2048	EPHB2	C0007134	Renal Cell Carcinoma	0.0010989071368524	BEFREE
2048	EPHB2	C0007137	Squamous cell carcinoma	0.0010989071368524	BEFREE
2048	EPHB2	C0023418	leukemia	0.0010989071368524	BEFREE
2048	EPHB2	C0023473	Myeloid Leukemia, Chronic	0.0010989071368524	BEFREE
2048	EPHB2	C0152013	Adenocarcinoma of lung (disorder)	0.0010989071368524	BEFREE
2048	EPHB2	C0238462	Medullary carcinoma of thyroid	0.0010989071368524	BEFREE
2048	EPHB2	C0279000	Liver and Intrahepatic Biliary Tract Carcinoma	0.0010989071368524	BEFREE
2048	EPHB2	C0345967	Malignant mesothelioma	0.0008241803526393	BEFREE
2048	EPHB2	C0598766	Leukemogenesis	0.0008241803526393	BEFREE
2048	EPHB2	C0686619	Secondary malignant neoplasm of lymph node	0.0008241803526393	BEFREE
2048	EPHB2	C0002726	Amyloidosis	0.0008241803526393	BEFREE
2048	EPHB2	C1290375	Mesothelioma (malignant, clinical disorder) (disorder)	0.0008241803526393	BEFREE
2048	EPHB2	C1378703	Renal carcinoma	0.0008241803526393	BEFREE
2048	EPHB2	C0007103	Malignant neoplasm of endometrium	0.0008241803526393	BEFREE
2048	EPHB2	C1519670	Tumor Angiogenesis	0.0008241803526393	BEFREE
2048	EPHB2	C1621958	Glioblastoma Multiforme	0.0008241803526393	BEFREE
2048	EPHB2	C0009319	Colitis	0.0008241803526393	BEFREE
2048	EPHB2	C1883486	Uterine Corpus Cancer	0.0008241803526393	BEFREE
2048	EPHB2	C0014175	Endometriosis	0.0008241803526393	BEFREE
2048	EPHB2	C3887505	DYSFUNCTION - SKIN DISORDERS	0.0008241803526393	BEFREE
2048	EPHB2	C0025149	Medulloblastoma	0.0008241803526393	BEFREE
2048	EPHB2	C0028754	Obesity	0.0008241803526393	BEFREE
2048	EPHB2	C0032019	Pituitary Neoplasms	0.0008241803526393	BEFREE
2048	EPHB2	C0042769	Virus Diseases	0.0008241803526393	BEFREE
2048	EPHB2	C0149925	Small cell carcinoma of lung	0.0008241803526393	BEFREE
2048	EPHB2	C0206656	Rhabdomyosarcoma, Embryonal	0.0008241803526393	BEFREE
2048	EPHB2	C0220633	Uveal melanoma	0.0008241803526393	BEFREE
2048	EPHB2	C0338656	Impaired cognition	0.0005494535684262	BEFREE
2048	EPHB2	C0374997	Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site	0.0005494535684262	BEFREE
2048	EPHB2	C0398738	Leukocyte adhesion deficiency type 1	0.0005494535684262	BEFREE
2048	EPHB2	C0399440	Hereditary gingival fibromatosis	0.0005494535684262	BEFREE
2048	EPHB2	C0494165	Secondary malignant neoplasm of liver	0.0005494535684262	BEFREE
2048	EPHB2	C0553723	Squamous cell carcinoma of skin	0.0005494535684262	BEFREE
2048	EPHB2	C0555198	Malignant Glioma	0.0005494535684262	BEFREE
2048	EPHB2	C0740457	Malignant neoplasm of kidney	0.0005494535684262	BEFREE
2048	EPHB2	C0948380	Colorectal cancer metastatic	0.0005494535684262	BEFREE
2048	EPHB2	C0002793	Anaplasia	0.0005494535684262	BEFREE
2048	EPHB2	C1168401	Squamous cell carcinoma of the head and neck	0.0005494535684262	BEFREE
2048	EPHB2	C0003850	Arteriosclerosis	0.0005494535684262	BEFREE
2048	EPHB2	C1261473	Sarcoma	0.0005494535684262	BEFREE
2048	EPHB2	C1266025	Traditional Serrated Adenoma	0.0005494535684262	BEFREE
2048	EPHB2	C1269683	Major Depressive Disorder	0.0005494535684262	BEFREE
2048	EPHB2	C0004153	Atherosclerosis	0.0005494535684262	BEFREE
2048	EPHB2	C0004352	Autistic Disorder	0.0005494535684262	BEFREE
2048	EPHB2	C0004364	Autoimmune Diseases	0.0005494535684262	BEFREE
2048	EPHB2	C1332460	Barrett's Adenocarcinoma	0.0005494535684262	BEFREE
2048	EPHB2	C1458155	Mammary Neoplasms	0.0005494535684262	BEFREE
2048	EPHB2	C0007114	Malignant neoplasm of skin	0.0005494535684262	BEFREE
2048	EPHB2	C1510472	Drug Dependence	0.0005494535684262	BEFREE
2048	EPHB2	C0008479	Chondrosarcoma	0.0005494535684262	BEFREE
2048	EPHB2	C0009241	Cognition Disorders	0.0005494535684262	BEFREE
2048	EPHB2	C0009324	Ulcerative Colitis	0.0005494535684262	BEFREE
2048	EPHB2	C2348820	Triple-Negative Breast Carcinoma	0.0005494535684262	BEFREE
2048	EPHB2	C0011644	Scleroderma	0.0005494535684262	BEFREE
2048	EPHB2	C0016057	Fibrosarcoma	0.0005494535684262	BEFREE
2048	EPHB2	C3854222	Human immunodeficiency virus (HIV) II infection category B1	0.0005494535684262	BEFREE
2048	EPHB2	C0019196	Hepatitis C	0.0005494535684262	BEFREE
2048	EPHB2	C0021051	Immunologic Deficiency Syndromes	0.0005494535684262	BEFREE
2048	EPHB2	C0021400	Influenza	0.0005494535684262	BEFREE
2048	EPHB2	C0023443	Hairy Cell Leukemia	0.0005494535684262	BEFREE
2048	EPHB2	C0023470	Myeloid Leukemia	0.0005494535684262	BEFREE
2048	EPHB2	C0025500	Mesothelioma	0.0005494535684262	BEFREE
2048	EPHB2	C0027831	Neurofibromatosis 1	0.0005494535684262	BEFREE
2048	EPHB2	C0029408	Degenerative polyarthritis	0.0005494535684262	BEFREE
2048	EPHB2	C0030297	Pancreatic Neoplasm	0.0005494535684262	BEFREE
2048	EPHB2	C0032002	Pituitary Diseases	0.0005494535684262	BEFREE
2048	EPHB2	C0032927	Precancerous Conditions	0.0005494535684262	BEFREE
2048	EPHB2	C0035335	Retinoblastoma	0.0005494535684262	BEFREE
2048	EPHB2	C0036220	Kaposi Sarcoma	0.0005494535684262	BEFREE
2048	EPHB2	C0036421	Systemic Scleroderma	0.0005494535684262	BEFREE
2048	EPHB2	C0041341	Tuberous Sclerosis	0.0005494535684262	BEFREE
2048	EPHB2	C0153452	Malignant neoplasm of gallbladder	0.0005494535684262	BEFREE
2048	EPHB2	C0153676	Secondary malignant neoplasm of lung	0.0005494535684262	BEFREE
2048	EPHB2	C0153690	Secondary malignant neoplasm of bone	0.0005494535684262	BEFREE
2048	EPHB2	C0206698	Cholangiocarcinoma	0.0005494535684262	BEFREE
2048	EPHB2	C0206754	Neuroendocrine Tumors	0.0005494535684262	BEFREE
2048	EPHB2	C0235782	Gallbladder Carcinoma	0.0005494535684262	BEFREE
2048	EPHB2	C0278883	Metastatic melanoma	0.0005494535684262	BEFREE
2048	EPHB2	C0279626	Squamous cell carcinoma of esophagus	0.0005494535684262	BEFREE
2048	EPHB2	C0281361	Adenocarcinoma of pancreas	0.0005494535684262	BEFREE
2048	EPHB2	C0302592	Cervix carcinoma	0.0005494535684262	BEFREE
2048	EPHB2	C0334583	Pilocytic Astrocytoma	0.0005494535684262	BEFREE
2048	EPHB2	C0334674	Acute panmyelosis with myelofibrosis	0.0002747267842131	BEFREE
2048	EPHB2	C0338106	Adenocarcinoma of colon	0.0002747267842131	BEFREE
2048	EPHB2	C0346360	Malignant melanoma of conjunctiva	0.0002747267842131	BEFREE
2048	EPHB2	C0349639	Juvenile Myelomonocytic Leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C0375023	Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	0.0002747267842131	BEFREE
2048	EPHB2	C0376544	Hematopoietic Neoplasms	0.0002747267842131	BEFREE
2048	EPHB2	C0398368	Lymphatic Abnormalities	0.0002747267842131	BEFREE
2048	EPHB2	C0521530	Lung consolidation	0.0002747267842131	BEFREE
2048	EPHB2	C0521585	Gastrointestinal mucositis	0.0002747267842131	BEFREE
2048	EPHB2	C0524851	Neurodegenerative Disorders	0.0002747267842131	BEFREE
2048	EPHB2	C0553580	Ewings sarcoma	0.0002747267842131	BEFREE
2048	EPHB2	C0553665	Skin endocrine disorder	0.0002747267842131	BEFREE
2048	EPHB2	C0587248	Costello syndrome (disorder)	0.0002747267842131	BEFREE
2048	EPHB2	C0598935	Tumor Initiation	0.0002747267842131	BEFREE
2048	EPHB2	C0677607	Hashimoto Disease	0.0002747267842131	BEFREE
2048	EPHB2	C0677936	Refractory cancer	0.0002747267842131	BEFREE
2048	EPHB2	C0751674	Lymphangioleiomyomatosis	0.0002747267842131	BEFREE
2048	EPHB2	C0751690	Malignant Peripheral Nerve Sheath Tumor	0.0002747267842131	BEFREE
2048	EPHB2	C0796004	Kabuki make-up syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C0812413	Malignant Pleural Mesothelioma	0.0002747267842131	BEFREE
2048	EPHB2	C0855082	Hodgkin's disease refractory	0.0002747267842131	BEFREE
2048	EPHB2	C0919267	ovarian neoplasm	0.0002747267842131	BEFREE
2048	EPHB2	C0947751	Vascular inflammations	0.0002747267842131	BEFREE
2048	EPHB2	C0001080	Achondroplasia	0.0002747267842131	BEFREE
2048	EPHB2	C0948008	Ischemic stroke	0.0002747267842131	BEFREE
2048	EPHB2	C0948192	primary infection nos	0.0002747267842131	BEFREE
2048	EPHB2	C1136084	Plasma cell dyscrasia	0.0002747267842131	BEFREE
2048	EPHB2	C1153706	Endometrial adenocarcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0003175	Anthrax disease	0.0002747267842131	BEFREE
2048	EPHB2	C0003864	Arthritis	0.0002747267842131	BEFREE
2048	EPHB2	C1275081	Cardio-facio-cutaneous syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C0004135	Ataxia Telangiectasia	0.0002747267842131	BEFREE
2048	EPHB2	C1292769	Precursor B-cell lymphoblastic leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C1302401	Adenoma of large intestine	0.0002747267842131	BEFREE
2048	EPHB2	C1319315	Adenocarcinoma of large intestine	0.0002747267842131	BEFREE
2048	EPHB2	C0004936	Mental disorders	0.0002747267842131	BEFREE
2048	EPHB2	C1327920	childhood chronic myelogenous leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C0005411	Biliary Atresia	0.0002747267842131	BEFREE
2048	EPHB2	C0005586	Bipolar Disorder	0.0002747267842131	BEFREE
2048	EPHB2	C1333064	Classical Hodgkin's Lymphoma	0.0002747267842131	BEFREE
2048	EPHB2	C0006118	Brain Neoplasms	0.0002747267842131	BEFREE
2048	EPHB2	C1334699	Mesenchymal Cell Neoplasm	0.0002747267842131	BEFREE
2048	EPHB2	C0006413	Burkitt Lymphoma	0.0002747267842131	BEFREE
2048	EPHB2	C1449563	Cardiomyopathy, Familial Idiopathic	0.0002747267842131	BEFREE
2048	EPHB2	C1510586	Autism Spectrum Disorders	0.0002747267842131	BEFREE
2048	EPHB2	C0007120	Bronchioloalveolar Adenocarcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0007130	Mucinous Adenocarcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C1519689	Tumor Promotion	0.0002747267842131	BEFREE
2048	EPHB2	C1527336	Sjogren's Syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C1531553	Dendritic cell neoplasm	0.0002747267842131	BEFREE
2048	EPHB2	C0007194	Hypertrophic Cardiomyopathy	0.0002747267842131	BEFREE
2048	EPHB2	C1559154	Rash and Dermatitis Adverse Event Associated with Chemoradiation	0.0002747267842131	BEFREE
2048	EPHB2	C0007847	Malignant tumor of cervix	0.0002747267842131	BEFREE
2048	EPHB2	C0008073	Developmental Disabilities	0.0002747267842131	BEFREE
2048	EPHB2	C1654637	androgen independent prostate cancer	0.0002747267842131	BEFREE
2048	EPHB2	C1658953	tumor vasculature	0.0002747267842131	BEFREE
2048	EPHB2	C0008487	Chordoma	0.0002747267842131	BEFREE
2048	EPHB2	C1708565	Invasive Skin Melanoma	0.0002747267842131	BEFREE
2048	EPHB2	C1849452	SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)	0.0002747267842131	BEFREE
2048	EPHB2	C1861305	TARSAL-CARPAL COALITION SYNDROME	0.0002747267842131	BEFREE
2048	EPHB2	C1862382	SVEINSSON CHORIORETINAL ATROPHY	0.0002747267842131	BEFREE
2048	EPHB2	C0009375	Colonic Neoplasms	0.0002747267842131	BEFREE
2048	EPHB2	C1868678	THANATOPHORIC DYSPLASIA, TYPE I (disorder)	0.0002747267842131	BEFREE
2048	EPHB2	C0010606	Adenoid Cystic Carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C1969623	NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME	0.0002747267842131	BEFREE
2048	EPHB2	C0010674	Cystic Fibrosis	0.0002747267842131	BEFREE
2048	EPHB2	C0011570	Mental Depression	0.0002747267842131	BEFREE
2048	EPHB2	C0011581	Depressive disorder	0.0002747267842131	BEFREE
2048	EPHB2	C2732618	Sessile Serrated Adenoma/Polyp	0.0002747267842131	BEFREE
2048	EPHB2	C2752147	XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	0.0002747267842131	BEFREE
2048	EPHB2	C0013336	Dwarfism	0.0002747267842131	BEFREE
2048	EPHB2	C2919945	Cavernous Hemangioma of Brain	0.0002747267842131	BEFREE
2048	EPHB2	C0014057	Japanese Encephalitis	0.0002747267842131	BEFREE
2048	EPHB2	C0014060	Encephalitis, St. Louis	0.0002747267842131	BEFREE
2048	EPHB2	C0014070	Encephalomyelitis	0.0002747267842131	BEFREE
2048	EPHB2	C2938905	Central Nervous System Sensitization	0.0002747267842131	BEFREE
2048	EPHB2	C3203102	Idiopathic pulmonary arterial hypertension	0.0002747267842131	BEFREE
2048	EPHB2	C3272363	Ischemic Cerebrovascular Accident	0.0002747267842131	BEFREE
2048	EPHB2	C0014544	Epilepsy	0.0002747267842131	BEFREE
2048	EPHB2	C3469521	FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	0.0002747267842131	BEFREE
2048	EPHB2	C0015625	Fanconi Anemia	0.0002747267842131	BEFREE
2048	EPHB2	C3489791	Parkinson Disease, Familial, Type 1	0.0002747267842131	BEFREE
2048	EPHB2	C0017185	Gastrointestinal Neoplasms	0.0002747267842131	BEFREE
2048	EPHB2	C3714948	PACHYONYCHIA CONGENITA 3	0.0002747267842131	BEFREE
2048	EPHB2	C0017661	IGA Glomerulonephritis	0.0002747267842131	BEFREE
2048	EPHB2	C4048306	Multiple endocrine neoplasia Type 2	0.0002747267842131	BEFREE
2048	EPHB2	C0017668	Focal glomerulosclerosis	0.0002747267842131	BEFREE
2048	EPHB2	C4048328	cervical cancer	0.0002747267842131	BEFREE
2048	EPHB2	C0018378	Guillain-Barre Syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C4049702	Focal Segmental Glomerulosclerosis, Not Otherwise Specified	0.0002747267842131	BEFREE
2048	EPHB2	C0018799	Heart Diseases	0.0002747267842131	BEFREE
2048	EPHB2	C4054122	Rat Adrenal Gland Pheochromocytoma	0.0002747267842131	BEFREE
2048	EPHB2	C0018916	Hemangioma	0.0002747267842131	BEFREE
2048	EPHB2	C0019100	Severe Dengue	0.0002747267842131	BEFREE
2048	EPHB2	C0019207	Hepatoma, Morris	0.0002747267842131	BEFREE
2048	EPHB2	C0019621	Histiocytosis, Langerhans-Cell	0.0002747267842131	BEFREE
2048	EPHB2	C0020179	Huntington Disease	0.0002747267842131	BEFREE
2048	EPHB2	C0020456	Hyperglycemia	0.0002747267842131	BEFREE
2048	EPHB2	C0020473	Hyperlipidemia	0.0002747267842131	BEFREE
2048	EPHB2	C0021053	Immune System Diseases	0.0002747267842131	BEFREE
2048	EPHB2	C0021841	Intestinal Neoplasms	0.0002747267842131	BEFREE
2048	EPHB2	C0022408	Arthropathy	0.0002747267842131	BEFREE
2048	EPHB2	C0022665	Kidney Neoplasm	0.0002747267842131	BEFREE
2048	EPHB2	C0022680	Polycystic Kidney Diseases	0.0002747267842131	BEFREE
2048	EPHB2	C0023267	Fibroid Tumor	0.0002747267842131	BEFREE
2048	EPHB2	C0023440	Acute Erythroblastic Leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C0023480	Leukemia, Myelomonocytic, Chronic	0.0002747267842131	BEFREE
2048	EPHB2	C0023487	Acute Promyelocytic Leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C0023493	Adult T-Cell Lymphoma/Leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C0024198	Lyme Disease	0.0002747267842131	BEFREE
2048	EPHB2	C0024305	Lymphoma, Non-Hodgkin	0.0002747267842131	BEFREE
2048	EPHB2	C0025268	Multiple Endocrine Neoplasia Type 2a	0.0002747267842131	BEFREE
2048	EPHB2	C0027708	Nephroblastoma	0.0002747267842131	BEFREE
2048	EPHB2	C0027830	neurofibroma	0.0002747267842131	BEFREE
2048	EPHB2	C0027962	Melanocytic nevus	0.0002747267842131	BEFREE
2048	EPHB2	C0029453	Osteopenia	0.0002747267842131	BEFREE
2048	EPHB2	C0030354	Papilloma	0.0002747267842131	BEFREE
2048	EPHB2	C0031099	Periodontitis	0.0002747267842131	BEFREE
2048	EPHB2	C0031117	Peripheral Neuropathy	0.0002747267842131	BEFREE
2048	EPHB2	C0032580	Adenomatous Polyposis Coli	0.0002747267842131	BEFREE
2048	EPHB2	C0033822	Pseudomyxoma Peritonei	0.0002747267842131	BEFREE
2048	EPHB2	C0034341	Pyruvate Carboxylase Deficiency Disease	0.0002747267842131	BEFREE
2048	EPHB2	C0035112	Reoviridae Infections	0.0002747267842131	BEFREE
2048	EPHB2	C0036341	Schizophrenia	0.0002747267842131	BEFREE
2048	EPHB2	C0036572	Seizures	0.0002747267842131	BEFREE
2048	EPHB2	C0039101	synovial sarcoma	0.0002747267842131	BEFREE
2048	EPHB2	C0039743	Thanatophoric Dysplasia	0.0002747267842131	BEFREE
2048	EPHB2	C0041582	Ulcer	0.0002747267842131	BEFREE
2048	EPHB2	C0041834	Erythema	0.0002747267842131	BEFREE
2048	EPHB2	C0042133	Uterine Fibroids	0.0002747267842131	BEFREE
2048	EPHB2	C0042214	Vaccinia	0.0002747267842131	BEFREE
2048	EPHB2	C0043395	Yellow Fever	0.0002747267842131	BEFREE
2048	EPHB2	C0078911	AIDS-Associated Nephropathy	0.0002747267842131	BEFREE
2048	EPHB2	C0079731	B-Cell Lymphomas	0.0002747267842131	BEFREE
2048	EPHB2	C0085136	Central Nervous System Neoplasms	0.0002747267842131	BEFREE
2048	EPHB2	C0085669	Acute leukemia	0.0002747267842131	BEFREE
2048	EPHB2	C0087012	Ataxia, Spinocerebellar	0.0002747267842131	BEFREE
2048	EPHB2	C0151779	Cutaneous Melanoma	0.0002747267842131	BEFREE
2048	EPHB2	C0151908	Dry skin	0.0002747267842131	BEFREE
2048	EPHB2	C0153381	Malignant neoplasm of mouth	0.0002747267842131	BEFREE
2048	EPHB2	C0155626	Acute myocardial infarction	0.0002747267842131	BEFREE
2048	EPHB2	C0162678	Neurofibromatoses	0.0002747267842131	BEFREE
2048	EPHB2	C0162820	Dermatitis, Allergic Contact	0.0002747267842131	BEFREE
2048	EPHB2	C0175695	Sotos' syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C0175704	LEOPARD Syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C0205748	Dysplastic Nevus	0.0002747267842131	BEFREE
2048	EPHB2	C0206655	Alveolar rhabdomyosarcoma	0.0002747267842131	BEFREE
2048	EPHB2	C0206664	Teratocarcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0206686	Adrenocortical carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0206694	Mucoepidermoid Carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0206727	Nerve Sheath Tumors	0.0002747267842131	BEFREE
2048	EPHB2	C0220641	Lip and Oral Cavity Carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0220650	Metastatic malignant neoplasm to brain	0.0002747267842131	BEFREE
2048	EPHB2	C0221715	CARCINOMA INTESTINAL	0.0002747267842131	BEFREE
2048	EPHB2	C0233514	Abnormal behavior	0.0002747267842131	BEFREE
2048	EPHB2	C0233794	Memory impairment	0.0002747267842131	BEFREE
2048	EPHB2	C0238198	Gastrointestinal Stromal Tumors	0.0002747267842131	BEFREE
2048	EPHB2	C0238461	Anaplastic thyroid carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0242596	Neoplasm, Residual	0.0002747267842131	BEFREE
2048	EPHB2	C0265252	Coffin-Lowry syndrome	0.0002747267842131	BEFREE
2048	EPHB2	C0266258	Congenital absence of liver	0.0002747267842131	BEFREE
2048	EPHB2	C0272173	Myelokathexis	0.0002747267842131	BEFREE
2048	EPHB2	C0278510	Medulloblastoma, Childhood	0.0002747267842131	BEFREE
2048	EPHB2	C0278688	Stage IV Ovarian Carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0279628	Adenocarcinoma Of Esophagus	0.0002747267842131	BEFREE
2048	EPHB2	C0279680	Transitional cell carcinoma of bladder	0.0002747267842131	BEFREE
2048	EPHB2	C0279702	Conventional (Clear Cell) Renal Cell Carcinoma	0.0002747267842131	BEFREE
2048	EPHB2	C0280100	solid tumor	0.0002747267842131	BEFREE
2048	EPHB2	C0280222	stage, pancreatic cancer	0.0002747267842131	BEFREE
2048	EPHB2	C0333875	High-Grade Squamous Intraepithelial Lesions	0.0002747267842131	BEFREE
2048	EPHB2	C0333983	Hyperplastic Polyp	0.0002747267842131	BEFREE
2048	EPHB2	C0334108	Multiple polyps	0.0002747267842131	BEFREE